Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Janssen Pharmaceuticals, dba Actelion Pharmaceutical
FDA Inspection
•Janssen Pharmaceuticals, dba Actelion Pharmaceutical•February 12, 2014

FDA Inspection 873005 - Janssen Pharmaceuticals, dba Actelion Pharmaceutical - February 12, 2014

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Janssen Pharmaceuticals, dba Actelion Pharmaceutical, with an inspection on February 12, 2014, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Janssen Pharmaceuticals, dba Actelion Pharmaceutical
Inspection Date
February 12, 2014
Product Type
Drugs
Office
Center for Drug Evaluation and Research
Open in Dashboard

ID · 9f647e8d-2e4c-4138-82ba-785dd4ad41db

Violation Codes2
21 CFR 314.80(b)21 CFR 314.80(c)(1)(i)

Full citation text and observation details available on the Dashboard.

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026, Global Key Solutions All rights reserved.